Bill Snyder Archive — Page 40 of 121
-
October 14, 2021
STAR Clinical Research Network to receive major grant renewal
Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States. -
October 7, 2021
Study seeks to improve kidney transplant outcomes among Black patients
-
October 7, 2021
Nominations sought for VUSM Research Staff Awards
-
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
October 1, 2021
VUMC research contributed to first COVID-19 pill now under review
Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19. -
September 29, 2021
Neurotransmitter transporters expert Amara set for Oct. 7 Discovery Lecture
Susan Amara, PhD, scientific director of the Intramural Research Program at the NIMH and an expert on the biology of neurotransmitter transporters, will deliver Vanderbilt's next Discovery Lecture via Zoom at 4 p.m., Thursday, Oct. 7.